查看购物车
  • Traditional Chinese
  • English
  • Japanese
封面
市场调查报告书
商品编码
1827395

手术器材市场（依产品、应用、技术、最终用户、材料、便携性和分销）－2025-2032 年全球预测

Surgical Devices Market by Product, Application, Technology, End User, Material, Portability, Distribution - Global Forecast 2025-2032
出版日期: | 出版商: 360iResearch | 英文 183 Pages | 商品交期: 最快1-2个工作天内

价格

※ 本网页内容可能与最新版本有所差异。详细情况请与我们联繫。

预计到 2032 年，手术器械市场规模将成长至 303.5 亿美元，复合年增长率为 7.97%。

主要市场统计数据
基准年2024年 164.2亿美元
预计2025年 177.1亿美元
预测年份：2032年 303.5亿美元
复合年增长率（%） 7.97%

权威介绍，概述手术器械市场的范围、目标和策略相关性，供企业决策者参考

外科器械领域正处于快速变化的临床需求、快速的技术进步和复杂的全球供应网络的交汇点。报告的引言将引导高阶主管读者了解影响每个装置类别产品开发、应用路径和竞争定位的关键因素。报告还说明了调查方法，并为负责采购、调查方法优先顺序确定和商业策略的高阶领导者阐明了用例。

引言首先从临床需求入手，将不断发展的医疗标准和人口压力点与器械製造商和医疗系统的创新重点联繫起来。然后，引言转向监管和报销格局，重点是阐述政策变化和付款人预期如何改变商业化轨迹。最后，引言重点探讨了製造地决策与物流弹性之间的相互作用，为后续探讨细分市场、区域动态和企业级策略的章节奠定了基准。本指南旨在帮助读者以务实的思维方式解读证据，并将这些见解应用于他们的近期规划週期。

技术、监管和市场力量如何快速再形成外科护理并重新定义跨装置类别的竞争优势

近年来，变革性变革加速了外科医疗服务和器材研发的步伐。微创手术和机器人辅助技术的进步不断重塑临床路径，缩短了病患復原时间，并扩大了门诊手术的可行性。同时，基于能量的平台和精准治疗方法日趋成熟，使得更有针对性的组织相互作用成为可能，并扩大了先前仅限于急性护理的器械的治疗范围。

同时，供应链弹性和製造敏捷性已成为策略规划的重中之重。製造商现在优先考虑灵活的生产线和双重采购，以减少中断。监管和合规格局也在发生变化，监管机构越来越重视真实世界证据和上市后监管，将其作为核准和生命週期管理流程的一部分。这些监管动态既带来了摩擦，也带来了机会。透过使临床证据产生与监管预期一致，企业可​​以加快商业化进程并减少报销摩擦。

最后，竞争架构正从单一产品转向生态系统。医疗技术、软体和服务领域的伙伴关係创造了捆绑产品，提供超越产品规格的临床和营运价值。随着支付方和医疗服务提供者对可证明的疗效和成本效益的要求越来越高，投资于综合护理解决方案和数据主导价值提案的公司将在采购谈判中占据差异化优势。

评估 2025 年美国关税对手术器械供应链、筹资策略和临床伙伴关係关係的累积影响

2025年美国关税政策的变化为本已复杂的全球供应环境带来了新的变数，改变了零件采购、製造地决策和跨境库存策略的经济性。关税促使企业更加重视供应链设计方案，并促使企业采取短期战术性应对措施，例如重新调整采购优先顺序、提高库存缓衝以及重新协商供应商合约以抵消成本上涨。从长远来看，这些调整将影响资本配置决策以及企业选择投资製造产能的领域。

除了直接的成本影响外，关税变化还影响了策略伙伴关係和临床合作。医疗保健提供者和医疗设备製造商重新评估了其供应商关係，以确保关键耗材的连续性并降低关税波动的影响。这导致人们对国内采购零件和其他区域供应商的兴趣日益浓厚。对供应链可视性和分析的投资也在加速成长。

最后，关税环境促使人们重新关注可製造性和材料选择，从而减少对关税敏感型投入的依赖。医疗器材製造商开始检验替代材料，并在临床可行的情况下调整产品结构。这种累积效应表明，贸易政策如何透过采购惯例、临床供应可靠性和长期创新策略产生连锁效应，从而鼓励在医疗器材的整个生命週期中重新平衡风险和韧性考量。

策略性细分洞察揭示了影响采用模式的产品、应用、技术、最终用户、材料、便携性和分销动态

了解市场区隔对于制定产品策略和商业化计划至关重要。依产品类型，市场分析包括内视镜、能量型设备、手术植入、手术器械和手术机器人。在能量型设备中，分析进一步区分了电外科、射频和超音波技术，反映了它们的临床用例和监管途径。手术植入分为心血管、牙科、神经和整形外科子领域，每个领域都有各自的临床证据要求和植入工作流程。手术器械分为通路器械、内视镜和通用器械，每种器械都会影响灭菌通讯协定、一次性策略和临床医生培训需求。

按应用领域，我们追踪心血管、一般外科、妇科、神经外科、整形外科和泌尿系统等领域的器械与适应症的交叉，将临床结果需求与采用时机和购买行为联繫起来。按技术领域，我们将重点放在高强度聚焦超音波、雷射手术、微创手术和开放性手术。微创手术类别进一步细分为内视镜、腹腔镜和机器人辅助技术，这是一个重要的区别，因为每种途径都需要不同的资金、手术人员和医疗保健提供者的培训投入。

从最终用户的角度来看，本研究评估了门诊手术中心、诊所、医院和专科手术中心的需求动态，并认识到医疗保健环境会影响购买週期、消毒基础设施需求和报销情况。材料也很重要。基于材料，设备和植入将从复合材料、聚合物、不銹钢和钛合金等选项中进行选择，这些选项会影响设备的寿命、生物相容性考量和成本结构。最后，基于便携性，市场区分了携带式和固定式解决方案。基于分销，分析考虑了直销、经销商和线上销售管道。这种分层细分提供了将产品架构与临床工作流程、采购行为和管道经济联繫起来的细緻入微的视图。

区域资讯重点在于全球主要市场和枢纽的需求驱动因素、法规环境、供应链弹性和创新热点

区域动态决定了技术的传播方式以及公司投资的优先顺序。在美洲，需求模式反映出私人医疗网络与大型公共医疗系统的集中，这些系统强调基于价值的采购和缩短病患住院时间。这种环境推动了人们对微创、可移动设备的有趣，这些设备可以减少住院时间和总费用。该地区的监管途径既强调安全性，也强调实际性能。因此，早期采用的公司通常依靠临床试验和健康经济证据的组合来说服大型医疗机构接受其价值提案。

欧洲、中东和非洲地区管理体制、采购框架和医疗资金筹措模式的差异性，既带来了复杂性，也带来了机会。报销体系的片段化需要就临床和经济价值进行区域性讨论。供应链的韧性仍然是全部区域的首要任务，製造商经常采用针对特定地区的製造和分销策略，以在遵守法规的同时保持价格竞争力。

亚太市场以其在特定都市区的快速技术应用、对手术机器人和微创平台的积极投资以及不断增长的国内製造能力而闻名。虽然技术应用的速度因当地临床医生的培训能力和资金筹措模式而异，但该地区总体而言为扩充性的製造策略和伙伴关係关係提供了肥沃的土壤，这些策略和合作伙伴关係既针对高容量城市中心，也针对不断扩张的次市场。区域领导者必须市场开发方法与当地采购驱动因素、监管预期和临床人员的实际情况一致，同时保持一致的全球产品和证据策略。

有关主要医疗设备製造商的产品系列、伙伴关係、製造地和投资趋势的全面竞争情报

企业级洞察，重点在于主要企业如何将策略转化为产品组合决策、合作伙伴选择和营运执行。顶级竞争对手专注于打造端到端解决方案，将设备、服务、软体和培训相结合，以确保临床疗效并满足医院品质目标。许多公司正在从单一产品竞争转向建构平台，透过耗材、资讯服务和特定流程产品实现持续的收益流。

策略联盟和併购持续重塑企业能力版图，中型市场公司往往成为大型公司收购的创新引擎，以加速进入相关技术领域。对于寻求限制单位成本波动并确保常用耗材供应的公司而言，优化生产布局和投资自动化是关键的差异化因素。同时，那些投资于强大的上市后监测和真实世界证据生成的公司正获得越来越多来自支付方和医疗系统的支持。

最后，商业模式正在不断发展。直销将继续在高接触、资本密集领域发挥关键作用，而经销商和数位通路将扩大低价或消费品驱动型产品线的覆盖范围。企业能否根据客户偏好调整销售模式（例如，选择门诊中心或三级医院）将影响采用速度和长期客户渗透率。这些趋势凸显了对产品组合管理、营运韧性和客户参与一体化方法的必要性。

为行业领导者提供切实可行的建议，优先考虑投资和伙伴关係，以加速采用安全高效的外科手术创新

领导者应优先考虑增强韧性并释放临床和商业潜力的行动。首先，将产品开发与明确的临床路径和报销证据需求相结合，确保新产品的上市直接解决医疗服务提供者的痛点并满足付款人阈值。儘早投资上市后数据收集，将其作为临床开发的重要组成部分，以缩短从核准到医院采用的时间。其次，透过重新评估供应链架构、实现供应商多元化、创建区域製造选项以及提高二级和三级采购的透明度，降低关税和地缘政治风险。这些措施可以降低营运风险并保障流程的连续性。

第三，我们将在技术、软体和服务领域建立伙伴关係，打造能够带来可衡量成果和营运效率的捆绑解决方案。这些合作关係不仅将提升我们的竞争地位，还将提高客户的转换成本。第四，我们将制定适合医疗保健环境的商业化策略，专注于资本密集型医院领域的直销，并利用门诊和耗材市场的经销商和数位管道。最后，我们将实施适应性定价和合约模式，以反映基于价值的采购趋势，从而能够更灵活地与付款人和大型医疗机构网路互动。

总的来说，这些建议在风险缓解和成长心态之间取得了平衡，为领导者提供了优先投资、建立策略联盟和实施证据生成以支持永续临床应用的现实蓝图。

概述资料来源、相关人员访谈、检验程序和研究限制的调查方法，以确保严格的证据综合

调查方法将系统性的二次研究与一手相关人员访谈和结构化检验相结合，以产生切实可行的见解。二次研究的输入包括监管备案文件、同行评审的临床文献、器械标籤文件和上市公司备案文件，以确定基准技术、材料和器械使用特性。一手研究包括对临床医生、供应链和采购主管、监管专家和行业策略专家的访谈，以了解现实世界中的应用障碍、采购偏好和未满足的临床需求。

本研究采用的分析架构包括价值链图谱绘製、基于情境的供应链压力测试、以及比较产品能力评估。在适当情况下，我们使用了证据三角检定来检验关于临床表现、生产影响和商业性吸引力的声明。该调查方法也揭示了一些局限性，例如报销途径的地区差异以及影响采用时机的临床医生培训项目的差异。为了解决这些局限性，本研究报告了定性判断的置信区间，并重点介绍了建议进行局部检验的案例。

总体而言，这种结构化方法可确保研究结果由多个数据流和相关人员的观点提供信息，并提供观察结果、支持证据和所呈现的结论之间的可追溯性，从而支持内部战略讨论和向外部相关人员的展示。

结论性综合强调了技术、监管和经济趋势对领导者塑造其手术器械组合的策略影响

结论部分总结了报告为高阶主管在技术进步和供应链日益复杂化的环境中提供的关键启示。微创手术和基于能量的平台的创新持续重塑临床工作流程，而监管和采购压力则凸显了可证明的成果和成本效益的重要性。供应链和贸易政策的变化迫使企业重新评估筹资策略，并投资于製造灵活性和视觉性。

综上所述，这些动态有利于那些拥有有效策略的公司，这些策略将临床差异化与营运韧性相结合，并为付款人和医疗保健提供者带来令人信服的成果。策略伙伴关係、有针对性的资本配置以及灵活的商业化模式将决定哪些公司将在医疗保健领域获得持续的采用。因此，领导者应利用报告的细分和区域洞察，优先考虑那些既符合近期营运需求，又符合长期投资组合目标的倡议。

这意味着，将产品设计、供应链策略和临床证据产生结合的公司最有能力将创新转化为持久的临床和商业性影响。

目录

第一章：前言

第二章调查方法

第三章执行摘要

第四章 市场概况

第五章 市场洞察

  • 人工智慧驱动的影像引导系统快速扩展，用于即时术中决策支持
  • 一次性手术器械的需求不断增加，以降低交叉污染的风险
  • 扩增实境迭加技术可提高腹腔镜和内视镜手术的精确度
  • 将无线远端监控感测器整合到手术工具中，用于预防性维护警报
  • 开发模组化机械臂，允许在复杂过程中灵活地进行多像限访问
  • 可携式消毒装置的出现，可用于资源有限的环境中的按需器械消毒
  • 增加生物可吸收植入装置的使用，以消除二次移除手术的需要

第六章：2025年美国关税的累积影响

第七章：人工智慧的累积影响，2025年

第 8 章：外科手术器械市场（按产品）

  • 内视镜检查
  • 基于能源的设备
    • 用于电外科手术
    • 射频
    • 超音波
  • 外科植入
    • 心血管系统
    • 牙科
    • 神经系统
    • 整形外科
  • 手术器械
    • 存取装置
    • 内视镜检查
    • 一般的
  • 手术机器人

第九章 手术器械市场（依应用）

  • 心血管系统
  • 一般的
  • 妇科
  • 神经系统
  • 整形外科
  • 泌尿系统

第十章 手术器械市场（依技术）

  • 高强度聚焦超音波
  • 雷射手术
  • 微创
    • 内视镜检查
    • 腹腔镜
    • 机器人协助
  • 开放性手术

第 11 章。手术器械市场（按最终用户划分）

  • 门诊手术中心
  • 诊所
  • 医院
  • 专科手术中心

第 12 章：手术器械市场（按材料）

  • 合成的
  • 聚合物
  • 不銹钢
  • 钛

第 13 章手术设备市场：便携性

  • 可携式的
  • 固定式

第 14 章。手术器械市场（按分布）

  • 直销
  • 经销商
  • 网上销售

第 15 章。按地区分類的手术器械市场

  • 美洲
    • 北美洲
    • 拉丁美洲
  • 欧洲、中东和非洲
    • 欧洲
    • 中东
    • 非洲
  • 亚太地区

第 16 章。手术器材市场（按类别）

  • ASEAN
  • GCC
  • EU
  • BRICS
  • G7
  • NATO

第 17 章。按国家/地区分類的手术器械市场

  • 美国
  • 加拿大
  • 墨西哥
  • 巴西
  • 英国
  • 德国
  • 法国
  • 俄罗斯
  • 义大利
  • 西班牙
  • 中国
  • 印度
  • 日本
  • 澳洲
  • 韩国

第十八章竞争格局

  • 2024年市占率分析
  • 2024年FPNV定位矩阵
  • 竞争分析
    • Medtronic plc
    • Johnson & Johnson
    • B. Braun Melsungen AG
    • Stryker Corporation
    • Zimmer Biomet Holdings, Inc.
    • Baxter International Inc.
    • Boston Scientific Corporation
    • Smith & Nephew plc
    • Siemens Healthineers AG
    • Intuitive Surgical, Inc.
Product Code: MRR-434CCDA04F06

The Surgical Devices Market is projected to grow by USD 30.35 billion at a CAGR of 7.97% by 2032.

KEY MARKET STATISTICS
Base Year [2024] USD 16.42 billion
Estimated Year [2025] USD 17.71 billion
Forecast Year [2032] USD 30.35 billion
CAGR (%) 7.97%

An authoritative introduction outlining the scope, objectives, and strategic relevance of the surgical devices landscape for executive decision-makers

The surgical devices domain sits at the intersection of fast-moving clinical need, rapid technological advancement, and complex global supply networks. This report's introduction orients executive readers to the principal forces shaping product development, adoption pathways, and competitive positioning across device categories. It frames the core research questions, outlines the methodological approach, and clarifies the practical use cases for senior leaders responsible for procurement, R&D prioritization, and commercial strategy.

Beginning with clinical imperatives, the introduction connects evolving standards of care and demographic pressure points to the innovation priorities of device manufacturers and health systems. It then transitions to the regulatory and reimbursement context, emphasizing how policy shifts and payer expectations alter commercialization pathways. Finally, the introduction highlights the interplay between manufacturing footprint decisions and logistical resilience, establishing a baseline for later sections that explore segmentation, regional dynamics, and company-level strategies. This orientation prepares readers to interpret the evidence with an operational mindset and to apply the insights to near-term planning cycles.

How rapid technological, regulatory, and market forces are reshaping surgical care delivery and redefining competitive advantage across device categories

Over the last several years, transformative shifts have accelerated the pace at which surgical care is delivered and devices are developed. Advances in minimally invasive and robotic-assisted techniques continue to redefine clinical pathways by reducing patient recovery time and expanding outpatient procedure feasibility. At the same time, energy-based platforms and precision modalities have matured, enabling more targeted tissue interaction and broadening the therapeutic footprint of devices previously confined to acute settings.

Concurrently, supply chain resilience and manufacturing agility have moved to the forefront of strategic planning. Manufacturers now prioritize flexible production lines and dual-source procurement to mitigate disruptions. Regulatory and compliance landscapes have also adapted, with regulators increasingly emphasizing real-world evidence and post-market surveillance as part of approval and lifecycle management processes. These regulatory dynamics create both friction and opportunity: companies that align clinical evidence generation with regulatory expectations can shorten commercialization timelines and reduce reimbursement friction.

Finally, the competitive architecture has shifted toward ecosystems rather than single-product plays. Partnerships across medtech, software, and services create bundled offerings that deliver clinical and operational value beyond product specifications. As payers and providers demand demonstrable outcomes and cost-effectiveness, companies that invest in integrated care solutions and data-driven value propositions will secure differentiated positions in procurement conversations.

Assessing the cumulative impact of United States tariffs in 2025 on supply chains, procurement strategies and clinical partnerships in surgical devices

United States tariff policy changes in 2025 introduced a new variable into an already complex global supply environment, altering the economics of component sourcing, manufacturing location decisions, and cross-border inventory strategies. Tariffs increased the impetus for companies to examine supply chain design choices, prompting near-term tactical responses such as reprioritizing procurement, raising inventory buffers, and renegotiating supplier contracts to offset incremental costs. Over time, these adjustments influence capital allocation decisions and where companies choose to invest in manufacturing capacity.

In addition to direct cost impacts, tariff shifts affected strategic partnerships and clinical collaborations. Providers and device manufacturers reassessed vendor relationships to ensure continuity of critical consumables and to reduce exposure to tariff volatility. This led to greater interest in domestically sourced components or alternate regional suppliers. Investment in supply chain visibility and analytics accelerated, as leaders sought to quantify exposure and model scenario impacts on product availability for elective and urgent procedures.

Finally, the tariff environment contributed to a renewed focus on design for manufacturability and material choices that reduce dependence on tariff-sensitive inputs. Organizations moved to validate alternative materials and to adapt product architectures where clinically feasible. These cumulative responses demonstrate how trade policy can cascade through procurement practices, clinical supply reliability, and long-term innovation strategies, prompting a rebalancing of risk and resilience considerations across the device lifecycle.

Strategic segmentation insights revealing product, application, technology, end user, material, portability and distribution dynamics shaping adoption patterns

Understanding segmentation is essential for shaping product strategy and commercialization plans. Based on Product, market analysis includes Endoscopes, Energy-Based Devices, Surgical Implants, Surgical Instruments, and Surgical Robots. Within Energy-Based Devices, the analysis further distinguishes Electrosurgical, Radio Frequency, and Ultrasound technologies, reflecting distinct clinical use cases and regulatory pathways. Surgical Implants are categorized into Cardiovascular, Dental, Neurological, and Orthopedic subsegments, each governed by unique clinical evidence requirements and implantation workflows. Surgical Instruments are differentiated across Access Devices, Endoscopic, and General instrument groups, which influence sterilization protocols, disposable strategies, and clinician training demands.

When viewed Based on Application, the report tracks device intersection with Cardiovascular, General, Gynecology, Neurological, Orthopedic, and Urology indications, connecting clinical outcomes imperatives to adoption timing and purchasing behavior. Based on Technology, technologies of interest include High-Intensity Focused Ultrasound, Laser Surgery, Minimally Invasive, and Open Surgery. The Minimally Invasive category is further subdivided into Endoscopic, Laparoscopic, and Robotic Assisted techniques, an important distinction because each pathway entails different capital equipment, procedural staffing, and training investments for provider organizations.

From the end-user perspective, Based on End User, the study evaluates demand dynamics across Ambulatory Surgical Centers, Clinics, Hospitals, and Specialty Surgical Centers, recognizing that care setting influences purchasing cycles, sterilization infrastructure needs, and reimbursement contexts. Materials matter as well; Based on Material, devices and implants are examined across Composite, Polymers, Stainless Steel, and Titanium selections, which affect device longevity, biocompatibility considerations, and cost structure. Finally, Based on Portability, the market differentiates Portable versus Stationary solutions, and Based on Distribution, the analysis considers Direct Sales, Distributors, and Online Sales channels. This layered segmentation provides a nuanced view that links product architecture to clinical workflows, procurement behavior, and channel economics.

Regional intelligence highlighting demand drivers, regulatory environments, supply chain resilience, and innovation hotspots across key global markets and hubs

Regional dynamics materially shape how technologies diffuse and how companies prioritize investments. In the Americas, demand patterns reflect a concentrated private provider network alongside large public health systems that emphasize value-based procurement and shorter patient stays. This environment drives interest in minimally invasive and ambulatory-capable devices that reduce length of stay and total episode cost. Regulatory pathways in the region emphasize both safety and real-world performance; as a result, early adopters often couple clinical pilots with health-economic evidence to convince larger providers of the value proposition.

In Europe, Middle East & Africa, heterogeneous regulatory regimes, procurement frameworks, and healthcare financing models create both complexity and opportunity. Fragmented reimbursement landscapes mean that localized clinical and economic value arguments prove necessary. Supply chain resilience remains a priority across the region, and manufacturers frequently adopt region-specific manufacturing or distribution strategies to maintain competitive pricing while meeting regulatory compliance.

Asia-Pacific markets are notable for rapid technology uptake in select urban centers, aggressive investment in surgical robotics and minimally invasive platforms, and growing domestic manufacturing capabilities. The pace of adoption varies with local clinician training capacity and funding models, but the region collectively represents fertile ground for scalable manufacturing strategies and partnerships that target both high-volume urban centers and expanding secondary markets. Across regions, leaders must tailor go-to-market approaches to local procurement drivers, regulatory expectations, and clinical workforce realities while maintaining a coherent global product and evidence strategy.

Competitive intelligence synthesizing product portfolios, partnerships, manufacturing footprints and investment trends among leading device manufacturers

Company-level insights focus on how leading organizations translate strategy into portfolio decisions, partner selection, and operational execution. Top competitors concentrate on building end-to-end solutions that combine devices with services, software, and training to lock in clinical outcomes and align with hospital quality goals. Many firms have moved beyond single-product competition to create platforms that enable recurring revenue streams through consumables, data services, and procedure-specific offerings.

Strategic alliances and M&A activity continue to reconfigure capability maps, with mid-sized firms often acting as innovation engines that larger players acquire to accelerate entry into adjacent technology areas. Manufacturing footprint optimization and investments in automation have become important differentiators for players seeking to reduce per-unit cost volatility and to maintain supply assurance for high-use consumables. Meanwhile, companies that demonstrate robust post-market surveillance and that invest in real-world evidence generation find improved receptivity among payers and health systems.

Finally, commercial models are evolving. Direct sales remain key in high-touch, capital-intensive segments, while distributors and digital channels expand access for lower-cost or consumable-driven product lines. The ability of a company to align its sales model to the customer setting-ambulatory center versus tertiary hospital, for example-affects adoption speed and long-term account penetration. These trends underscore the need for an integrated approach to portfolio management, operational resilience, and customer engagement.

Actionable recommendations for industry leaders to prioritize investments and partnerships that accelerate safe and efficient surgical innovation adoption

Leaders should prioritize actions that enhance resilience while unlocking clinical and commercial upside. First, align product development with clearly defined clinical pathways and reimbursement evidence needs so that new launches directly address provider pain points and payer thresholds. Invest early in post-market data collection as an integral part of clinical development to shorten the time from approval to widespread hospital adoption. Second, re-evaluate supply chain architectures to reduce tariff and geopolitical exposure by diversifying suppliers, creating regional manufacturing options, and increasing visibility into tier-two and tier-three sourcing. These steps will reduce operational risk and protect procedure continuity.

Third, cultivate partnerships across technology, software, and services to build bundled solutions that deliver measurable outcomes and operational efficiencies. Such collaborations not only improve competitiveness but also create higher switching costs for customers. Fourth, tailor commercialization strategies to care settings by deploying direct sales in capital-intensive hospital segments while leveraging distributors and digital channels for ambulatory and consumable-driven markets. Finally, embed adaptive pricing and contracting approaches that reflect value-based procurement trends, enabling more flexible engagement with payers and large provider networks.

Taken together, these recommendations balance risk mitigation with growth orientation, providing leaders with a pragmatic roadmap for prioritizing investments, forging strategic alliances, and operationalizing evidence generation to support sustainable clinical adoption.

Research methodology outlining data sources, stakeholder interviews, validation procedures and study limitations to ensure rigorous evidence synthesis

The research methodology combines systematic secondary research with primary stakeholder engagement and structured validation to produce actionable findings. Secondary inputs included regulatory filings, peer-reviewed clinical literature, device labeling documents, and public company filings to establish baseline technology, material, and device usage characteristics. Primary research included interviews with clinicians, supply chain and procurement executives, regulatory specialists, and industry strategists to capture real-world adoption barriers, procurement preferences, and unmet clinical needs.

Analytical frameworks applied in the study include value chain mapping, scenario-based supply chain stress testing, and comparative product capability assessment. Where appropriate, evidence triangulation validated claims about clinical performance, manufacturing implications, and commercial traction. The methodology also documents limitations, including variability across local reimbursement pathways and differences in clinician training programs that affect adoption timing. To address these constraints, the study reports confidence bounds around qualitative judgments and specifies instances where local validation is recommended.

Overall, this structured approach ensures the findings are grounded in multiple data streams and stakeholder perspectives. It also creates traceability between observations, underlying evidence, and the conclusions presented, supporting both internal strategy discussions and external stakeholder briefings.

Conclusive synthesis articulating the strategic implications of technological, regulatory and economic trends for leaders shaping surgical device portfolios

The conclusion synthesizes the report's principal takeaways for executives seeking to navigate an environment of technological advance and supply chain complexity. Technological innovation in minimally invasive procedures and energy-based platforms continues to reshape clinical workflows, while regulatory and procurement pressures emphasize the need for demonstrable outcomes and cost-effectiveness. Supply chain and trade policy shifts compel organizations to reassess sourcing strategies and to invest in manufacturing flexibility and visibility.

Taken together, these dynamics favor companies that can combine clinical differentiation with operational resilience and who can present compelling, evidence-based value propositions to payers and providers. Strategic partnerships, targeted capital allocation, and adaptable commercialization models will determine which organizations capture sustained adoption across care settings. Leaders should therefore apply the report's segmentation and regional insights to prioritize initiatives that align with both near-term operational needs and long-term portfolio ambitions.

In sum, the surgical devices landscape rewards integrated thinking: those that coordinate product design, supply chain strategy, and clinical evidence generation will be best positioned to convert innovation into lasting clinical and commercial impact.

Table of Contents

1. Preface

  • 1.1. Objectives of the Study
  • 1.2. Market Segmentation & Coverage
  • 1.3. Years Considered for the Study
  • 1.4. Currency & Pricing
  • 1.5. Language
  • 1.6. Stakeholders

2. Research Methodology

3. Executive Summary

4. Market Overview

5. Market Insights

  • 5.1. Rapid expansion of AI-driven image guidance systems for real-time intraoperative decision support
  • 5.2. Growing demand for single-use disposable surgical instruments to reduce cross-contamination risks
  • 5.3. Adoption of augmented reality overlays in laparoscopic and endoscopic surgery for improved precision
  • 5.4. Integration of wireless remote monitoring sensors in surgical tools for proactive maintenance alerts
  • 5.5. Development of modular robotic arms enabling flexible multi-quadrant access during complex procedures
  • 5.6. Emergence of portable point-of-care sterilization units for on-demand instrument decontamination in low-resource settings
  • 5.7. Rising utilization of bioresorbable implantable devices to eliminate the need for secondary removal surgeries

6. Cumulative Impact of United States Tariffs 2025

7. Cumulative Impact of Artificial Intelligence 2025

8. Surgical Devices Market, by Product

  • 8.1. Endoscopes
  • 8.2. Energy-Based Devices
    • 8.2.1. Electrosurgical
    • 8.2.2. Radio Frequency
    • 8.2.3. Ultrasound
  • 8.3. Surgical Implants
    • 8.3.1. Cardiovascular
    • 8.3.2. Dental
    • 8.3.3. Neurological
    • 8.3.4. Orthopedic
  • 8.4. Surgical Instruments
    • 8.4.1. Access Devices
    • 8.4.2. Endoscopic
    • 8.4.3. General
  • 8.5. Surgical Robots

9. Surgical Devices Market, by Application

  • 9.1. Cardiovascular
  • 9.2. General
  • 9.3. Gynecology
  • 9.4. Neurological
  • 9.5. Orthopedic
  • 9.6. Urology

10. Surgical Devices Market, by Technology

  • 10.1. High-Intensity Focused Ultrasound
  • 10.2. Laser Surgery
  • 10.3. Minimally Invasive
    • 10.3.1. Endoscopic
    • 10.3.2. Laparoscopic
    • 10.3.3. Robotic Assisted
  • 10.4. Open Surgery

11. Surgical Devices Market, by End User

  • 11.1. Ambulatory Surgical Centers
  • 11.2. Clinics
  • 11.3. Hospitals
  • 11.4. Specialty Surgical Centers

12. Surgical Devices Market, by Material

  • 12.1. Composite
  • 12.2. Polymers
  • 12.3. Stainless Steel
  • 12.4. Titanium

13. Surgical Devices Market, by Portability

  • 13.1. Portable
  • 13.2. Stationary

14. Surgical Devices Market, by Distribution

  • 14.1. Direct Sales
  • 14.2. Distributors
  • 14.3. Online Sales

15. Surgical Devices Market, by Region

  • 15.1. Americas
    • 15.1.1. North America
    • 15.1.2. Latin America
  • 15.2. Europe, Middle East & Africa
    • 15.2.1. Europe
    • 15.2.2. Middle East
    • 15.2.3. Africa
  • 15.3. Asia-Pacific

16. Surgical Devices Market, by Group

  • 16.1. ASEAN
  • 16.2. GCC
  • 16.3. European Union
  • 16.4. BRICS
  • 16.5. G7
  • 16.6. NATO

17. Surgical Devices Market, by Country

  • 17.1. United States
  • 17.2. Canada
  • 17.3. Mexico
  • 17.4. Brazil
  • 17.5. United Kingdom
  • 17.6. Germany
  • 17.7. France
  • 17.8. Russia
  • 17.9. Italy
  • 17.10. Spain
  • 17.11. China
  • 17.12. India
  • 17.13. Japan
  • 17.14. Australia
  • 17.15. South Korea

18. Competitive Landscape

  • 18.1. Market Share Analysis, 2024
  • 18.2. FPNV Positioning Matrix, 2024
  • 18.3. Competitive Analysis
    • 18.3.1. Medtronic plc
    • 18.3.2. Johnson & Johnson
    • 18.3.3. B. Braun Melsungen AG
    • 18.3.4. Stryker Corporation
    • 18.3.5. Zimmer Biomet Holdings, Inc.
    • 18.3.6. Baxter International Inc.
    • 18.3.7. Boston Scientific Corporation
    • 18.3.8. Smith & Nephew plc
    • 18.3.9. Siemens Healthineers AG
    • 18.3.10. Intuitive Surgical, Inc.

LIST OF FIGURES

  • FIGURE 1. GLOBAL SURGICAL DEVICES MARKET SIZE, 2018-2032 (USD MILLION)
  • FIGURE 2. GLOBAL SURGICAL DEVICES MARKET SIZE, BY PRODUCT, 2024 VS 2032 (%)
  • FIGURE 3. GLOBAL SURGICAL DEVICES MARKET SIZE, BY PRODUCT, 2024 VS 2025 VS 2032 (USD MILLION)
  • FIGURE 4. GLOBAL SURGICAL DEVICES MARKET SIZE, BY APPLICATION, 2024 VS 2032 (%)
  • FIGURE 5. GLOBAL SURGICAL DEVICES MARKET SIZE, BY APPLICATION, 2024 VS 2025 VS 2032 (USD MILLION)
  • FIGURE 6. GLOBAL SURGICAL DEVICES MARKET SIZE, BY TECHNOLOGY, 2024 VS 2032 (%)
  • FIGURE 7. GLOBAL SURGICAL DEVICES MARKET SIZE, BY TECHNOLOGY, 2024 VS 2025 VS 2032 (USD MILLION)
  • FIGURE 8. GLOBAL SURGICAL DEVICES MARKET SIZE, BY END USER, 2024 VS 2032 (%)
  • FIGURE 9. GLOBAL SURGICAL DEVICES MARKET SIZE, BY END USER, 2024 VS 2025 VS 2032 (USD MILLION)
  • FIGURE 10. GLOBAL SURGICAL DEVICES MARKET SIZE, BY MATERIAL, 2024 VS 2032 (%)
  • FIGURE 11. GLOBAL SURGICAL DEVICES MARKET SIZE, BY MATERIAL, 2024 VS 2025 VS 2032 (USD MILLION)
  • FIGURE 12. GLOBAL SURGICAL DEVICES MARKET SIZE, BY PORTABILITY, 2024 VS 2032 (%)
  • FIGURE 13. GLOBAL SURGICAL DEVICES MARKET SIZE, BY PORTABILITY, 2024 VS 2025 VS 2032 (USD MILLION)
  • FIGURE 14. GLOBAL SURGICAL DEVICES MARKET SIZE, BY DISTRIBUTION, 2024 VS 2032 (%)
  • FIGURE 15. GLOBAL SURGICAL DEVICES MARKET SIZE, BY DISTRIBUTION, 2024 VS 2025 VS 2032 (USD MILLION)
  • FIGURE 16. GLOBAL SURGICAL DEVICES MARKET SIZE, BY REGION, 2024 VS 2025 VS 2032 (USD MILLION)
  • FIGURE 17. AMERICAS SURGICAL DEVICES MARKET SIZE, BY SUBREGION, 2024 VS 2025 VS 2032 (USD MILLION)
  • FIGURE 18. NORTH AMERICA SURGICAL DEVICES MARKET SIZE, BY COUNTRY, 2024 VS 2025 VS 2032 (USD MILLION)
  • FIGURE 19. LATIN AMERICA SURGICAL DEVICES MARKET SIZE, BY COUNTRY, 2024 VS 2025 VS 2032 (USD MILLION)
  • FIGURE 20. EUROPE, MIDDLE EAST & AFRICA SURGICAL DEVICES MARKET SIZE, BY SUBREGION, 2024 VS 2025 VS 2032 (USD MILLION)
  • FIGURE 21. EUROPE SURGICAL DEVICES MARKET SIZE, BY COUNTRY, 2024 VS 2025 VS 2032 (USD MILLION)
  • FIGURE 22. MIDDLE EAST SURGICAL DEVICES MARKET SIZE, BY COUNTRY, 2024 VS 2025 VS 2032 (USD MILLION)
  • FIGURE 23. AFRICA SURGICAL DEVICES MARKET SIZE, BY COUNTRY, 2024 VS 2025 VS 2032 (USD MILLION)
  • FIGURE 24. ASIA-PACIFIC SURGICAL DEVICES MARKET SIZE, BY COUNTRY, 2024 VS 2025 VS 2032 (USD MILLION)
  • FIGURE 25. GLOBAL SURGICAL DEVICES MARKET SIZE, BY GROUP, 2024 VS 2025 VS 2032 (USD MILLION)
  • FIGURE 26. ASEAN SURGICAL DEVICES MARKET SIZE, BY COUNTRY, 2024 VS 2025 VS 2032 (USD MILLION)
  • FIGURE 27. GCC SURGICAL DEVICES MARKET SIZE, BY COUNTRY, 2024 VS 2025 VS 2032 (USD MILLION)
  • FIGURE 28. EUROPEAN UNION SURGICAL DEVICES MARKET SIZE, BY COUNTRY, 2024 VS 2025 VS 2032 (USD MILLION)
  • FIGURE 29. BRICS SURGICAL DEVICES MARKET SIZE, BY COUNTRY, 2024 VS 2025 VS 2032 (USD MILLION)
  • FIGURE 30. G7 SURGICAL DEVICES MARKET SIZE, BY COUNTRY, 2024 VS 2025 VS 2032 (USD MILLION)
  • FIGURE 31. NATO SURGICAL DEVICES MARKET SIZE, BY COUNTRY, 2024 VS 2025 VS 2032 (USD MILLION)
  • FIGURE 32. GLOBAL SURGICAL DEVICES MARKET SIZE, BY COUNTRY, 2024 VS 2025 VS 2032 (USD MILLION)
  • FIGURE 33. SURGICAL DEVICES MARKET SHARE, BY KEY PLAYER, 2024
  • FIGURE 34. SURGICAL DEVICES MARKET, FPNV POSITIONING MATRIX, 2024

LIST OF TABLES

  • TABLE 1. SURGICAL DEVICES MARKET SEGMENTATION & COVERAGE
  • TABLE 2. UNITED STATES DOLLAR EXCHANGE RATE, 2018-2024
  • TABLE 3. GLOBAL SURGICAL DEVICES MARKET SIZE, 2018-2024 (USD MILLION)
  • TABLE 4. GLOBAL SURGICAL DEVICES MARKET SIZE, 2025-2032 (USD MILLION)
  • TABLE 5. GLOBAL SURGICAL DEVICES MARKET SIZE, BY PRODUCT, 2018-2024 (USD MILLION)
  • TABLE 6. GLOBAL SURGICAL DEVICES MARKET SIZE, BY PRODUCT, 2025-2032 (USD MILLION)
  • TABLE 7. GLOBAL SURGICAL DEVICES MARKET SIZE, BY ENDOSCOPES, BY REGION, 2018-2024 (USD MILLION)
  • TABLE 8. GLOBAL SURGICAL DEVICES MARKET SIZE, BY ENDOSCOPES, BY REGION, 2025-2032 (USD MILLION)
  • TABLE 9. GLOBAL SURGICAL DEVICES MARKET SIZE, BY ENDOSCOPES, BY GROUP, 2018-2024 (USD MILLION)
  • TABLE 10. GLOBAL SURGICAL DEVICES MARKET SIZE, BY ENDOSCOPES, BY GROUP, 2025-2032 (USD MILLION)
  • TABLE 11. GLOBAL SURGICAL DEVICES MARKET SIZE, BY ENDOSCOPES, BY COUNTRY, 2018-2024 (USD MILLION)
  • TABLE 12. GLOBAL SURGICAL DEVICES MARKET SIZE, BY ENDOSCOPES, BY COUNTRY, 2025-2032 (USD MILLION)
  • TABLE 13. GLOBAL SURGICAL DEVICES MARKET SIZE, BY ENERGY-BASED DEVICES, 2018-2024 (USD MILLION)
  • TABLE 14. GLOBAL SURGICAL DEVICES MARKET SIZE, BY ENERGY-BASED DEVICES, 2025-2032 (USD MILLION)
  • TABLE 15. GLOBAL SURGICAL DEVICES MARKET SIZE, BY ENERGY-BASED DEVICES, BY REGION, 2018-2024 (USD MILLION)
  • TABLE 16. GLOBAL SURGICAL DEVICES MARKET SIZE, BY ENERGY-BASED DEVICES, BY REGION, 2025-2032 (USD MILLION)
  • TABLE 17. GLOBAL SURGICAL DEVICES MARKET SIZE, BY ENERGY-BASED DEVICES, BY GROUP, 2018-2024 (USD MILLION)
  • TABLE 18. GLOBAL SURGICAL DEVICES MARKET SIZE, BY ENERGY-BASED DEVICES, BY GROUP, 2025-2032 (USD MILLION)
  • TABLE 19. GLOBAL SURGICAL DEVICES MARKET SIZE, BY ENERGY-BASED DEVICES, BY COUNTRY, 2018-2024 (USD MILLION)
  • TABLE 20. GLOBAL SURGICAL DEVICES MARKET SIZE, BY ENERGY-BASED DEVICES, BY COUNTRY, 2025-2032 (USD MILLION)
  • TABLE 21. GLOBAL SURGICAL DEVICES MARKET SIZE, BY ELECTROSURGICAL, BY REGION, 2018-2024 (USD MILLION)
  • TABLE 22. GLOBAL SURGICAL DEVICES MARKET SIZE, BY ELECTROSURGICAL, BY REGION, 2025-2032 (USD MILLION)
  • TABLE 23. GLOBAL SURGICAL DEVICES MARKET SIZE, BY ELECTROSURGICAL, BY GROUP, 2018-2024 (USD MILLION)
  • TABLE 24. GLOBAL SURGICAL DEVICES MARKET SIZE, BY ELECTROSURGICAL, BY GROUP, 2025-2032 (USD MILLION)
  • TABLE 25. GLOBAL SURGICAL DEVICES MARKET SIZE, BY ELECTROSURGICAL, BY COUNTRY, 2018-2024 (USD MILLION)
  • TABLE 26. GLOBAL SURGICAL DEVICES MARKET SIZE, BY ELECTROSURGICAL, BY COUNTRY, 2025-2032 (USD MILLION)
  • TABLE 27. GLOBAL SURGICAL DEVICES MARKET SIZE, BY RADIO FREQUENCY, BY REGION, 2018-2024 (USD MILLION)
  • TABLE 28. GLOBAL SURGICAL DEVICES MARKET SIZE, BY RADIO FREQUENCY, BY REGION, 2025-2032 (USD MILLION)
  • TABLE 29. GLOBAL SURGICAL DEVICES MARKET SIZE, BY RADIO FREQUENCY, BY GROUP, 2018-2024 (USD MILLION)
  • TABLE 30. GLOBAL SURGICAL DEVICES MARKET SIZE, BY RADIO FREQUENCY, BY GROUP, 2025-2032 (USD MILLION)
  • TABLE 31. GLOBAL SURGICAL DEVICES MARKET SIZE, BY RADIO FREQUENCY, BY COUNTRY, 2018-2024 (USD MILLION)
  • TABLE 32. GLOBAL SURGICAL DEVICES MARKET SIZE, BY RADIO FREQUENCY, BY COUNTRY, 2025-2032 (USD MILLION)
  • TABLE 33. GLOBAL SURGICAL DEVICES MARKET SIZE, BY ULTRASOUND, BY REGION, 2018-2024 (USD MILLION)
  • TABLE 34. GLOBAL SURGICAL DEVICES MARKET SIZE, BY ULTRASOUND, BY REGION, 2025-2032 (USD MILLION)
  • TABLE 35. GLOBAL SURGICAL DEVICES MARKET SIZE, BY ULTRASOUND, BY GROUP, 2018-2024 (USD MILLION)
  • TABLE 36. GLOBAL SURGICAL DEVICES MARKET SIZE, BY ULTRASOUND, BY GROUP, 2025-2032 (USD MILLION)
  • TABLE 37. GLOBAL SURGICAL DEVICES MARKET SIZE, BY ULTRASOUND, BY COUNTRY, 2018-2024 (USD MILLION)
  • TABLE 38. GLOBAL SURGICAL DEVICES MARKET SIZE, BY ULTRASOUND, BY COUNTRY, 2025-2032 (USD MILLION)
  • TABLE 39. GLOBAL SURGICAL DEVICES MARKET SIZE, BY SURGICAL IMPLANTS, 2018-2024 (USD MILLION)
  • TABLE 40. GLOBAL SURGICAL DEVICES MARKET SIZE, BY SURGICAL IMPLANTS, 2025-2032 (USD MILLION)
  • TABLE 41. GLOBAL SURGICAL DEVICES MARKET SIZE, BY SURGICAL IMPLANTS, BY REGION, 2018-2024 (USD MILLION)
  • TABLE 42. GLOBAL SURGICAL DEVICES MARKET SIZE, BY SURGICAL IMPLANTS, BY REGION, 2025-2032 (USD MILLION)
  • TABLE 43. GLOBAL SURGICAL DEVICES MARKET SIZE, BY SURGICAL IMPLANTS, BY GROUP, 2018-2024 (USD MILLION)
  • TABLE 44. GLOBAL SURGICAL DEVICES MARKET SIZE, BY SURGICAL IMPLANTS, BY GROUP, 2025-2032 (USD MILLION)
  • TABLE 45. GLOBAL SURGICAL DEVICES MARKET SIZE, BY SURGICAL IMPLANTS, BY COUNTRY, 2018-2024 (USD MILLION)
  • TABLE 46. GLOBAL SURGICAL DEVICES MARKET SIZE, BY SURGICAL IMPLANTS, BY COUNTRY, 2025-2032 (USD MILLION)
  • TABLE 47. GLOBAL SURGICAL DEVICES MARKET SIZE, BY CARDIOVASCULAR, BY REGION, 2018-2024 (USD MILLION)
  • TABLE 48. GLOBAL SURGICAL DEVICES MARKET SIZE, BY CARDIOVASCULAR, BY REGION, 2025-2032 (USD MILLION)
  • TABLE 49. GLOBAL SURGICAL DEVICES MARKET SIZE, BY CARDIOVASCULAR, BY GROUP, 2018-2024 (USD MILLION)
  • TABLE 50. GLOBAL SURGICAL DEVICES MARKET SIZE, BY CARDIOVASCULAR, BY GROUP, 2025-2032 (USD MILLION)
  • TABLE 51. GLOBAL SURGICAL DEVICES MARKET SIZE, BY CARDIOVASCULAR, BY COUNTRY, 2018-2024 (USD MILLION)
  • TABLE 52. GLOBAL SURGICAL DEVICES MARKET SIZE, BY CARDIOVASCULAR, BY COUNTRY, 2025-2032 (USD MILLION)
  • TABLE 53. GLOBAL SURGICAL DEVICES MARKET SIZE, BY DENTAL, BY REGION, 2018-2024 (USD MILLION)
  • TABLE 54. GLOBAL SURGICAL DEVICES MARKET SIZE, BY DENTAL, BY REGION, 2025-2032 (USD MILLION)
  • TABLE 55. GLOBAL SURGICAL DEVICES MARKET SIZE, BY DENTAL, BY GROUP, 2018-2024 (USD MILLION)
  • TABLE 56. GLOBAL SURGICAL DEVICES MARKET SIZE, BY DENTAL, BY GROUP, 2025-2032 (USD MILLION)
  • TABLE 57. GLOBAL SURGICAL DEVICES MARKET SIZE, BY DENTAL, BY COUNTRY, 2018-2024 (USD MILLION)
  • TABLE 58. GLOBAL SURGICAL DEVICES MARKET SIZE, BY DENTAL, BY COUNTRY, 2025-2032 (USD MILLION)
  • TABLE 59. GLOBAL SURGICAL DEVICES MARKET SIZE, BY NEUROLOGICAL, BY REGION, 2018-2024 (USD MILLION)
  • TABLE 60. GLOBAL SURGICAL DEVICES MARKET SIZE, BY NEUROLOGICAL, BY REGION, 2025-2032 (USD MILLION)
  • TABLE 61. GLOBAL SURGICAL DEVICES MARKET SIZE, BY NEUROLOGICAL, BY GROUP, 2018-2024 (USD MILLION)
  • TABLE 62. GLOBAL SURGICAL DEVICES MARKET SIZE, BY NEUROLOGICAL, BY GROUP, 2025-2032 (USD MILLION)
  • TABLE 63. GLOBAL SURGICAL DEVICES MARKET SIZE, BY NEUROLOGICAL, BY COUNTRY, 2018-2024 (USD MILLION)
  • TABLE 64. GLOBAL SURGICAL DEVICES MARKET SIZE, BY NEUROLOGICAL, BY COUNTRY, 2025-2032 (USD MILLION)
  • TABLE 65. GLOBAL SURGICAL DEVICES MARKET SIZE, BY ORTHOPEDIC, BY REGION, 2018-2024 (USD MILLION)
  • TABLE 66. GLOBAL SURGICAL DEVICES MARKET SIZE, BY ORTHOPEDIC, BY REGION, 2025-2032 (USD MILLION)
  • TABLE 67. GLOBAL SURGICAL DEVICES MARKET SIZE, BY ORTHOPEDIC, BY GROUP, 2018-2024 (USD MILLION)
  • TABLE 68. GLOBAL SURGICAL DEVICES MARKET SIZE, BY ORTHOPEDIC, BY GROUP, 2025-2032 (USD MILLION)
  • TABLE 69. GLOBAL SURGICAL DEVICES MARKET SIZE, BY ORTHOPEDIC, BY COUNTRY, 2018-2024 (USD MILLION)
  • TABLE 70. GLOBAL SURGICAL DEVICES MARKET SIZE, BY ORTHOPEDIC, BY COUNTRY, 2025-2032 (USD MILLION)
  • TABLE 71. GLOBAL SURGICAL DEVICES MARKET SIZE, BY SURGICAL INSTRUMENTS, 2018-2024 (USD MILLION)
  • TABLE 72. GLOBAL SURGICAL DEVICES MARKET SIZE, BY SURGICAL INSTRUMENTS, 2025-2032 (USD MILLION)
  • TABLE 73. GLOBAL SURGICAL DEVICES MARKET SIZE, BY SURGICAL INSTRUMENTS, BY REGION, 2018-2024 (USD MILLION)
  • TABLE 74. GLOBAL SURGICAL DEVICES MARKET SIZE, BY SURGICAL INSTRUMENTS, BY REGION, 2025-2032 (USD MILLION)
  • TABLE 75. GLOBAL SURGICAL DEVICES MARKET SIZE, BY SURGICAL INSTRUMENTS, BY GROUP, 2018-2024 (USD MILLION)
  • TABLE 76. GLOBAL SURGICAL DEVICES MARKET SIZE, BY SURGICAL INSTRUMENTS, BY GROUP, 2025-2032 (USD MILLION)
  • TABLE 77. GLOBAL SURGICAL DEVICES MARKET SIZE, BY SURGICAL INSTRUMENTS, BY COUNTRY, 2018-2024 (USD MILLION)
  • TABLE 78. GLOBAL SURGICAL DEVICES MARKET SIZE, BY SURGICAL INSTRUMENTS, BY COUNTRY, 2025-2032 (USD MILLION)
  • TABLE 79. GLOBAL SURGICAL DEVICES MARKET SIZE, BY ACCESS DEVICES, BY REGION, 2018-2024 (USD MILLION)
  • TABLE 80. GLOBAL SURGICAL DEVICES MARKET SIZE, BY ACCESS DEVICES, BY REGION, 2025-2032 (USD MILLION)
  • TABLE 81. GLOBAL SURGICAL DEVICES MARKET SIZE, BY ACCESS DEVICES, BY GROUP, 2018-2024 (USD MILLION)
  • TABLE 82. GLOBAL SURGICAL DEVICES MARKET SIZE, BY ACCESS DEVICES, BY GROUP, 2025-2032 (USD MILLION)
  • TABLE 83. GLOBAL SURGICAL DEVICES MARKET SIZE, BY ACCESS DEVICES, BY COUNTRY, 2018-2024 (USD MILLION)
  • TABLE 84. GLOBAL SURGICAL DEVICES MARKET SIZE, BY ACCESS DEVICES, BY COUNTRY, 2025-2032 (USD MILLION)
  • TABLE 85. GLOBAL SURGICAL DEVICES MARKET SIZE, BY ENDOSCOPIC, BY REGION, 2018-2024 (USD MILLION)
  • TABLE 86. GLOBAL SURGICAL DEVICES MARKET SIZE, BY ENDOSCOPIC, BY REGION, 2025-2032 (USD MILLION)
  • TABLE 87. GLOBAL SURGICAL DEVICES MARKET SIZE, BY ENDOSCOPIC, BY GROUP, 2018-2024 (USD MILLION)
  • TABLE 88. GLOBAL SURGICAL DEVICES MARKET SIZE, BY ENDOSCOPIC, BY GROUP, 2025-2032 (USD MILLION)
  • TABLE 89. GLOBAL SURGICAL DEVICES MARKET SIZE, BY ENDOSCOPIC, BY COUNTRY, 2018-2024 (USD MILLION)
  • TABLE 90. GLOBAL SURGICAL DEVICES MARKET SIZE, BY ENDOSCOPIC, BY COUNTRY, 2025-2032 (USD MILLION)
  • TABLE 91. GLOBAL SURGICAL DEVICES MARKET SIZE, BY GENERAL, BY REGION, 2018-2024 (USD MILLION)
  • TABLE 92. GLOBAL SURGICAL DEVICES MARKET SIZE, BY GENERAL, BY REGION, 2025-2032 (USD MILLION)
  • TABLE 93. GLOBAL SURGICAL DEVICES MARKET SIZE, BY GENERAL, BY GROUP, 2018-2024 (USD MILLION)
  • TABLE 94. GLOBAL SURGICAL DEVICES MARKET SIZE, BY GENERAL, BY GROUP, 2025-2032 (USD MILLION)
  • TABLE 95. GLOBAL SURGICAL DEVICES MARKET SIZE, BY GENERAL, BY COUNTRY, 2018-2024 (USD MILLION)
  • TABLE 96. GLOBAL SURGICAL DEVICES MARKET SIZE, BY GENERAL, BY COUNTRY, 2025-2032 (USD MILLION)
  • TABLE 97. GLOBAL SURGICAL DEVICES MARKET SIZE, BY SURGICAL ROBOTS, BY REGION, 2018-2024 (USD MILLION)
  • TABLE 98. GLOBAL SURGICAL DEVICES MARKET SIZE, BY SURGICAL ROBOTS, BY REGION, 2025-2032 (USD MILLION)
  • TABLE 99. GLOBAL SURGICAL DEVICES MARKET SIZE, BY SURGICAL ROBOTS, BY GROUP, 2018-2024 (USD MILLION)
  • TABLE 100. GLOBAL SURGICAL DEVICES MARKET SIZE, BY SURGICAL ROBOTS, BY GROUP, 2025-2032 (USD MILLION)
  • TABLE 101. GLOBAL SURGICAL DEVICES MARKET SIZE, BY SURGICAL ROBOTS, BY COUNTRY, 2018-2024 (USD MILLION)
  • TABLE 102. GLOBAL SURGICAL DEVICES MARKET SIZE, BY SURGICAL ROBOTS, BY COUNTRY, 2025-2032 (USD MILLION)
  • TABLE 103. GLOBAL SURGICAL DEVICES MARKET SIZE, BY APPLICATION, 2018-2024 (USD MILLION)
  • TABLE 104. GLOBAL SURGICAL DEVICES MARKET SIZE, BY APPLICATION, 2025-2032 (USD MILLION)
  • TABLE 105. GLOBAL SURGICAL DEVICES MARKET SIZE, BY CARDIOVASCULAR, BY REGION, 2018-2024 (USD MILLION)
  • TABLE 106. GLOBAL SURGICAL DEVICES MARKET SIZE, BY CARDIOVASCULAR, BY REGION, 2025-2032 (USD MILLION)
  • TABLE 107. GLOBAL SURGICAL DEVICES MARKET SIZE, BY CARDIOVASCULAR, BY GROUP, 2018-2024 (USD MILLION)
  • TABLE 108. GLOBAL SURGICAL DEVICES MARKET SIZE, BY CARDIOVASCULAR, BY GROUP, 2025-2032 (USD MILLION)
  • TABLE 109. GLOBAL SURGICAL DEVICES MARKET SIZE, BY CARDIOVASCULAR, BY COUNTRY, 2018-2024 (USD MILLION)
  • TABLE 110. GLOBAL SURGICAL DEVICES MARKET SIZE, BY CARDIOVASCULAR, BY COUNTRY, 2025-2032 (USD MILLION)
  • TABLE 111. GLOBAL SURGICAL DEVICES MARKET SIZE, BY GENERAL, BY REGION, 2018-2024 (USD MILLION)
  • TABLE 112. GLOBAL SURGICAL DEVICES MARKET SIZE, BY GENERAL, BY REGION, 2025-2032 (USD MILLION)
  • TABLE 113. GLOBAL SURGICAL DEVICES MARKET SIZE, BY GENERAL, BY GROUP, 2018-2024 (USD MILLION)
  • TABLE 114. GLOBAL SURGICAL DEVICES MARKET SIZE, BY GENERAL, BY GROUP, 2025-2032 (USD MILLION)
  • TABLE 115. GLOBAL SURGICAL DEVICES MARKET SIZE, BY GENERAL, BY COUNTRY, 2018-2024 (USD MILLION)
  • TABLE 116. GLOBAL SURGICAL DEVICES MARKET SIZE, BY GENERAL, BY COUNTRY, 2025-2032 (USD MILLION)
  • TABLE 117. GLOBAL SURGICAL DEVICES MARKET SIZE, BY GYNECOLOGY, BY REGION, 2018-2024 (USD MILLION)
  • TABLE 118. GLOBAL SURGICAL DEVICES MARKET SIZE, BY GYNECOLOGY, BY REGION, 2025-2032 (USD MILLION)
  • TABLE 119. GLOBAL SURGICAL DEVICES MARKET SIZE, BY GYNECOLOGY, BY GROUP, 2018-2024 (USD MILLION)
  • TABLE 120. GLOBAL SURGICAL DEVICES MARKET SIZE, BY GYNECOLOGY, BY GROUP, 2025-2032 (USD MILLION)
  • TABLE 121. GLOBAL SURGICAL DEVICES MARKET SIZE, BY GYNECOLOGY, BY COUNTRY, 2018-2024 (USD MILLION)
  • TABLE 122. GLOBAL SURGICAL DEVICES MARKET SIZE, BY GYNECOLOGY, BY COUNTRY, 2025-2032 (USD MILLION)
  • TABLE 123. GLOBAL SURGICAL DEVICES MARKET SIZE, BY NEUROLOGICAL, BY REGION, 2018-2024 (USD MILLION)
  • TABLE 124. GLOBAL SURGICAL DEVICES MARKET SIZE, BY NEUROLOGICAL, BY REGION, 2025-2032 (USD MILLION)
  • TABLE 125. GLOBAL SURGICAL DEVICES MARKET SIZE, BY NEUROLOGICAL, BY GROUP, 2018-2024 (USD MILLION)
  • TABLE 126. GLOBAL SURGICAL DEVICES MARKET SIZE, BY NEUROLOGICAL, BY GROUP, 2025-2032 (USD MILLION)
  • TABLE 127. GLOBAL SURGICAL DEVICES MARKET SIZE, BY NEUROLOGICAL, BY COUNTRY, 2018-2024 (USD MILLION)
  • TABLE 128. GLOBAL SURGICAL DEVICES MARKET SIZE, BY NEUROLOGICAL, BY COUNTRY, 2025-2032 (USD MILLION)
  • TABLE 129. GLOBAL SURGICAL DEVICES MARKET SIZE, BY ORTHOPEDIC, BY REGION, 2018-2024 (USD MILLION)
  • TABLE 130. GLOBAL SURGICAL DEVICES MARKET SIZE, BY ORTHOPEDIC, BY REGION, 2025-2032 (USD MILLION)
  • TABLE 131. GLOBAL SURGICAL DEVICES MARKET SIZE, BY ORTHOPEDIC, BY GROUP, 2018-2024 (USD MILLION)
  • TABLE 132. GLOBAL SURGICAL DEVICES MARKET SIZE, BY ORTHOPEDIC, BY GROUP, 2025-2032 (USD MILLION)
  • TABLE 133. GLOBAL SURGICAL DEVICES MARKET SIZE, BY ORTHOPEDIC, BY COUNTRY, 2018-2024 (USD MILLION)
  • TABLE 134. GLOBAL SURGICAL DEVICES MARKET SIZE, BY ORTHOPEDIC, BY COUNTRY, 2025-2032 (USD MILLION)
  • TABLE 135. GLOBAL SURGICAL DEVICES MARKET SIZE, BY UROLOGY, BY REGION, 2018-2024 (USD MILLION)
  • TABLE 136. GLOBAL SURGICAL DEVICES MARKET SIZE, BY UROLOGY, BY REGION, 2025-2032 (USD MILLION)
  • TABLE 137. GLOBAL SURGICAL DEVICES MARKET SIZE, BY UROLOGY, BY GROUP, 2018-2024 (USD MILLION)
  • TABLE 138. GLOBAL SURGICAL DEVICES MARKET SIZE, BY UROLOGY, BY GROUP, 2025-2032 (USD MILLION)
  • TABLE 139. GLOBAL SURGICAL DEVICES MARKET SIZE, BY UROLOGY, BY COUNTRY, 2018-2024 (USD MILLION)
  • TABLE 140. GLOBAL SURGICAL DEVICES MARKET SIZE, BY UROLOGY, BY COUNTRY, 2025-2032 (USD MILLION)
  • TABLE 141. GLOBAL SURGICAL DEVICES MARKET SIZE, BY TECHNOLOGY, 2018-2024 (USD MILLION)
  • TABLE 142. GLOBAL SURGICAL DEVICES MARKET SIZE, BY TECHNOLOGY, 2025-2032 (USD MILLION)
  • TABLE 143. GLOBAL SURGICAL DEVICES MARKET SIZE, BY HIGH-INTENSITY FOCUSED ULTRASOUND, BY REGION, 2018-2024 (USD MILLION)
  • TABLE 144. GLOBAL SURGICAL DEVICES MARKET SIZE, BY HIGH-INTENSITY FOCUSED ULTRASOUND, BY REGION, 2025-2032 (USD MILLION)
  • TABLE 145. GLOBAL SURGICAL DEVICES MARKET SIZE, BY HIGH-INTENSITY FOCUSED ULTRASOUND, BY GROUP, 2018-2024 (USD MILLION)
  • TABLE 146. GLOBAL SURGICAL DEVICES MARKET SIZE, BY HIGH-INTENSITY FOCUSED ULTRASOUND, BY GROUP, 2025-2032 (USD MILLION)
  • TABLE 147. GLOBAL SURGICAL DEVICES MARKET SIZE, BY HIGH-INTENSITY FOCUSED ULTRASOUND, BY COUNTRY, 2018-2024 (USD MILLION)
  • TABLE 148. GLOBAL SURGICAL DEVICES MARKET SIZE, BY HIGH-INTENSITY FOCUSED ULTRASOUND, BY COUNTRY, 2025-2032 (USD MILLION)
  • TABLE 149. GLOBAL SURGICAL DEVICES MARKET SIZE, BY LASER SURGERY, BY REGION, 2018-2024 (USD MILLION)
  • TABLE 150. GLOBAL SURGICAL DEVICES MARKET SIZE, BY LASER SURGERY, BY REGION, 2025-2032 (USD MILLION)
  • TABLE 151. GLOBAL SURGICAL DEVICES MARKET SIZE, BY LASER SURGERY, BY GROUP, 2018-2024 (USD MILLION)
  • TABLE 152. GLOBAL SURGICAL DEVICES MARKET SIZE, BY LASER SURGERY, BY GROUP, 2025-2032 (USD MILLION)
  • TABLE 153. GLOBAL SURGICAL DEVICES MARKET SIZE, BY LASER SURGERY, BY COUNTRY, 2018-2024 (USD MILLION)
  • TABLE 154. GLOBAL SURGICAL DEVICES MARKET SIZE, BY LASER SURGERY, BY COUNTRY, 2025-2032 (USD MILLION)
  • TABLE 155. GLOBAL SURGICAL DEVICES MARKET SIZE, BY MINIMALLY INVASIVE, 2018-2024 (USD MILLION)
  • TABLE 156. GLOBAL SURGICAL DEVICES MARKET SIZE, BY MINIMALLY INVASIVE, 2025-2032 (USD MILLION)
  • TABLE 157. GLOBAL SURGICAL DEVICES MARKET SIZE, BY MINIMALLY INVASIVE, BY REGION, 2018-2024 (USD MILLION)
  • TABLE 158. GLOBAL SURGICAL DEVICES MARKET SIZE, BY MINIMALLY INVASIVE, BY REGION, 2025-2032 (USD MILLION)
  • TABLE 159. GLOBAL SURGICAL DEVICES MARKET SIZE, BY MINIMALLY INVASIVE, BY GROUP, 2018-2024 (USD MILLION)
  • TABLE 160. GLOBAL SURGICAL DEVICES MARKET SIZE, BY MINIMALLY INVASIVE, BY GROUP, 2025-2032 (USD MILLION)
  • TABLE 161. GLOBAL SURGICAL DEVICES MARKET SIZE, BY MINIMALLY INVASIVE, BY COUNTRY, 2018-2024 (USD MILLION)
  • TABLE 162. GLOBAL SURGICAL DEVICES MARKET SIZE, BY MINIMALLY INVASIVE, BY COUNTRY, 2025-2032 (USD MILLION)
  • TABLE 163. GLOBAL SURGICAL DEVICES MARKET SIZE, BY ENDOSCOPIC, BY REGION, 2018-2024 (USD MILLION)
  • TABLE 164. GLOBAL SURGICAL DEVICES MARKET SIZE, BY ENDOSCOPIC, BY REGION, 2025-2032 (USD MILLION)
  • TABLE 165. GLOBAL SURGICAL DEVICES MARKET SIZE, BY ENDOSCOPIC, BY GROUP, 2018-2024 (USD MILLION)
  • TABLE 166. GLOBAL SURGICAL DEVICES MARKET SIZE, BY ENDOSCOPIC, BY GROUP, 2025-2032 (USD MILLION)
  • TABLE 167. GLOBAL SURGICAL DEVICES MARKET SIZE, BY ENDOSCOPIC, BY COUNTRY, 2018-2024 (USD MILLION)
  • TABLE 168. GLOBAL SURGICAL DEVICES MARKET SIZE, BY ENDOSCOPIC, BY COUNTRY, 2025-2032 (USD MILLION)
  • TABLE 169. GLOBAL SURGICAL DEVICES MARKET SIZE, BY LAPAROSCOPIC, BY REGION, 2018-2024 (USD MILLION)
  • TABLE 170. GLOBAL SURGICAL DEVICES MARKET SIZE, BY LAPAROSCOPIC, BY REGION, 2025-2032 (USD MILLION)
  • TABLE 171. GLOBAL SURGICAL DEVICES MARKET SIZE, BY LAPAROSCOPIC, BY GROUP, 2018-2024 (USD MILLION)
  • TABLE 172. GLOBAL SURGICAL DEVICES MARKET SIZE, BY LAPAROSCOPIC, BY GROUP, 2025-2032 (USD MILLION)
  • TABLE 173. GLOBAL SURGICAL DEVICES MARKET SIZE, BY LAPAROSCOPIC, BY COUNTRY, 2018-2024 (USD MILLION)
  • TABLE 174. GLOBAL SURGICAL DEVICES MARKET SIZE, BY LAPAROSCOPIC, BY COUNTRY, 2025-2032 (USD MILLION)
  • TABLE 175. GLOBAL SURGICAL DEVICES MARKET SIZE, BY ROBOTIC ASSISTED, BY REGION, 2018-2024 (USD MILLION)
  • TABLE 176. GLOBAL SURGICAL DEVICES MARKET SIZE, BY ROBOTIC ASSISTED, BY REGION, 2025-2032 (USD MILLION)
  • TABLE 177. GLOBAL SURGICAL DEVICES MARKET SIZE, BY ROBOTIC ASSISTED, BY GROUP, 2018-2024 (USD MILLION)
  • TABLE 178. GLOBAL SURGICAL DEVICES MARKET SIZE, BY ROBOTIC ASSISTED, BY GROUP, 2025-2032 (USD MILLION)
  • TABLE 179. GLOBAL SURGICAL DEVICES MARKET SIZE, BY ROBOTIC ASSISTED, BY COUNTRY, 2018-2024 (USD MILLION)
  • TABLE 180. GLOBAL SURGICAL DEVICES MARKET SIZE, BY ROBOTIC ASSISTED, BY COUNTRY, 2025-2032 (USD MILLION)
  • TABLE 181. GLOBAL SURGICAL DEVICES MARKET SIZE, BY OPEN SURGERY, BY REGION, 2018-2024 (USD MILLION)
  • TABLE 182. GLOBAL SURGICAL DEVICES MARKET SIZE, BY OPEN SURGERY, BY REGION, 2025-2032 (USD MILLION)
  • TABLE 183. GLOBAL SURGICAL DEVICES MARKET SIZE, BY OPEN SURGERY, BY GROUP, 2018-2024 (USD MILLION)
  • TABLE 184. GLOBAL SURGICAL DEVICES MARKET SIZE, BY OPEN SURGERY, BY GROUP, 2025-2032 (USD MILLION)
  • TABLE 185. GLOBAL SURGICAL DEVICES MARKET SIZE, BY OPEN SURGERY, BY COUNTRY, 2018-2024 (USD MILLION)
  • TABLE 186. GLOBAL SURGICAL DEVICES MARKET SIZE, BY OPEN SURGERY, BY COUNTRY, 2025-2032 (USD MILLION)
  • TABLE 187. GLOBAL SURGICAL DEVICES MARKET SIZE, BY END USER, 2018-2024 (USD MILLION)
  • TABLE 188. GLOBAL SURGICAL DEVICES MARKET SIZE, BY END USER, 2025-2032 (USD MILLION)
  • TABLE 189. GLOBAL SURGICAL DEVICES MARKET SIZE, BY AMBULATORY SURGICAL CENTERS, BY REGION, 2018-2024 (USD MILLION)
  • TABLE 190. GLOBAL SURGICAL DEVICES MARKET SIZE, BY AMBULATORY SURGICAL CENTERS, BY REGION, 2025-2032 (USD MILLION)
  • TABLE 191. GLOBAL SURGICAL DEVICES MARKET SIZE, BY AMBULATORY SURGICAL CENTERS, BY GROUP, 2018-2024 (USD MILLION)
  • TABLE 192. GLOBAL SURGICAL DEVICES MARKET SIZE, BY AMBULATORY SURGICAL CENTERS, BY GROUP, 2025-2032 (USD MILLION)
  • TABLE 193. GLOBAL SURGICAL DEVICES MARKET SIZE, BY AMBULATORY SURGICAL CENTERS, BY COUNTRY, 2018-2024 (USD MILLION)
  • TABLE 194. GLOBAL SURGICAL DEVICES MARKET SIZE, BY AMBULATORY SURGICAL CENTERS, BY COUNTRY, 2025-2032 (USD MILLION)
  • TABLE 195. GLOBAL SURGICAL DEVICES MARKET SIZE, BY CLINICS, BY REGION, 2018-2024 (USD MILLION)
  • TABLE 196. GLOBAL SURGICAL DEVICES MARKET SIZE, BY CLINICS, BY REGION, 2025-2032 (USD MILLION)
  • TABLE 197. GLOBAL SURGICAL DEVICES MARKET SIZE, BY CLINICS, BY GROUP, 2018-2024 (USD MILLION)
  • TABLE 198. GLOBAL SURGICAL DEVICES MARKET SIZE, BY CLINICS, BY GROUP, 2025-2032 (USD MILLION)
  • TABLE 199. GLOBAL SURGICAL DEVICES MARKET SIZE, BY CLINICS, BY COUNTRY, 2018-2024 (USD MILLION)
  • TABLE 200. GLOBAL SURGICAL DEVICES MARKET SIZE, BY CLINICS, BY COUNTRY, 2025-2032 (USD MILLION)
  • TABLE 201. GLOBAL SURGICAL DEVICES MARKET SIZE, BY HOSPITALS, BY REGION, 2018-2024 (USD MILLION)
  • TABLE 202. GLOBAL SURGICAL DEVICES MARKET SIZE, BY HOSPITALS, BY REGION, 2025-2032 (USD MILLION)
  • TABLE 203. GLOBAL SURGICAL DEVICES MARKET SIZE, BY HOSPITALS, BY GROUP, 2018-2024 (USD MILLION)
  • TABLE 204. GLOBAL SURGICAL DEVICES MARKET SIZE, BY HOSPITALS, BY GROUP, 2025-2032 (USD MILLION)
  • TABLE 205. GLOBAL SURGICAL DEVICES MARKET SIZE, BY HOSPITALS, BY COUNTRY, 2018-2024 (USD MILLION)
  • TABLE 206. GLOBAL SURGICAL DEVICES MARKET SIZE, BY HOSPITALS, BY COUNTRY, 2025-2032 (USD MILLION)
  • TABLE 207. GLOBAL SURGICAL DEVICES MARKET SIZE, BY SPECIALTY SURGICAL CENTERS, BY REGION, 2018-2024 (USD MILLION)
  • TABLE 208. GLOBAL SURGICAL DEVICES MARKET SIZE, BY SPECIALTY SURGICAL CENTERS, BY REGION, 2025-2032 (USD MILLION)
  • TABLE 209. GLOBAL SURGICAL DEVICES MARKET SIZE, BY SPECIALTY SURGICAL CENTERS, BY GROUP, 2018-2024 (USD MILLION)
  • TABLE 210. GLOBAL SURGICAL DEVICES MARKET SIZE, BY SPECIALTY SURGICAL CENTERS, BY GROUP, 2025-2032 (USD MILLION)
  • TABLE 211. GLOBAL SURGICAL DEVICES MARKET SIZE, BY SPECIALTY SURGICAL CENTERS, BY COUNTRY, 2018-2024 (USD MILLION)
  • TABLE 212. GLOBAL SURGICAL DEVICES MARKET SIZE, BY SPECIALTY SURGICAL CENTERS, BY COUNTRY, 2025-2032 (USD MILLION)
  • TABLE 213. GLOBAL SURGICAL DEVICES MARKET SIZE, BY MATERIAL, 2018-2024 (USD MILLION)
  • TABLE 214. GLOBAL SURGICAL DEVICES MARKET SIZE, BY MATERIAL, 2025-2032 (USD MILLION)
  • TABLE 215. GLOBAL SURGICAL DEVICES MARKET SIZE, BY COMPOSITE, BY REGION, 2018-2024 (USD MILLION)
  • TABLE 216. GLOBAL SURGICAL DEVICES MARKET SIZE, BY COMPOSITE, BY REGION, 2025-2032 (USD MILLION)
  • TABLE 217. GLOBAL SURGICAL DEVICES MARKET SIZE, BY COMPOSITE, BY GROUP, 2018-2024 (USD MILLION)
  • TABLE 218. GLOBAL SURGICAL DEVICES MARKET SIZE, BY COMPOSITE, BY GROUP, 2025-2032 (USD MILLION)
  • TABLE 219. GLOBAL SURGICAL DEVICES MARKET SIZE, BY COMPOSITE, BY COUNTRY, 2018-2024 (USD MILLION)
  • TABLE 220. GLOBAL SURGICAL DEVICES MARKET SIZE, BY COMPOSITE, BY COUNTRY, 2025-2032 (USD MILLION)
  • TABLE 221. GLOBAL SURGICAL DEVICES MARKET SIZE, BY POLYMERS, BY REGION, 2018-2024 (USD MILLION)
  • TABLE 222. GLOBAL SURGICAL DEVICES MARKET SIZE, BY POLYMERS, BY REGION, 2025-2032 (USD MILLION)
  • TABLE 223. GLOBAL SURGICAL DEVICES MARKET SIZE, BY POLYMERS, BY GROUP, 2018-2024 (USD MILLION)
  • TABLE 224. GLOBAL SURGICAL DEVICES MARKET SIZE, BY POLYMERS, BY GROUP, 2025-2032 (USD MILLION)
  • TABLE 225. GLOBAL SURGICAL DEVICES MARKET SIZE, BY POLYMERS, BY COUNTRY, 2018-2024 (USD MILLION)
  • TABLE 226. GLOBAL SURGICAL DEVICES MARKET SIZE, BY POLYMERS, BY COUNTRY, 2025-2032 (USD MILLION)
  • TABLE 227. GLOBAL SURGICAL DEVICES MARKET SIZE, BY STAINLESS STEEL, BY REGION, 2018-2024 (USD MILLION)
  • TABLE 228. GLOBAL SURGICAL DEVICES MARKET SIZE, BY STAINLESS STEEL, BY REGION, 2025-2032 (USD MILLION)
  • TABLE 229. GLOBAL SURGICAL DEVICES MARKET SIZE, BY STAINLESS STEEL, BY GROUP, 2018-2024 (USD MILLION)
  • TABLE 230. GLOBAL SURGICAL DEVICES MARKET SIZE, BY STAINLESS STEEL, BY GROUP, 2025-2032 (USD MILLION)
  • TABLE 231. GLOBAL SURGICAL DEVICES MARKET SIZE, BY STAINLESS STEEL, BY COUNTRY, 2018-2024 (USD MILLION)
  • TABLE 232. GLOBAL SURGICAL DEVICES MARKET SIZE, BY STAINLESS STEEL, BY COUNTRY, 2025-2032 (USD MILLION)
  • TABLE 233. GLOBAL SURGICAL DEVICES MARKET SIZE, BY TITANIUM, BY REGION, 2018-2024 (USD MILLION)
  • TABLE 234. GLOBAL SURGICAL DEVICES MARKET SIZE, BY TITANIUM, BY REGION, 2025-2032 (USD MILLION)
  • TABLE 235. GLOBAL SURGICAL DEVICES MARKET SIZE, BY TITANIUM, BY GROUP, 2018-2024 (USD MILLION)
  • TABLE 236. GLOBAL SURGICAL DEVICES MARKET SIZE, BY TITANIUM, BY GROUP, 2025-2032 (USD MILLION)
  • TABLE 237. GLOBAL SURGICAL DEVICES MARKET SIZE, BY TITANIUM, BY COUNTRY, 2018-2024 (USD MILLION)
  • TABLE 238. GLOBAL SURGICAL DEVICES MARKET SIZE, BY TITANIUM, BY COUNTRY, 2025-2032 (USD MILLION)
  • TABLE 239. GLOBAL SURGICAL DEVICES MARKET SIZE, BY PORTABILITY, 2018-2024 (USD MILLION)
  • TABLE 240. GLOBAL SURGICAL DEVICES MARKET SIZE, BY PORTABILITY, 2025-2032 (USD MILLION)
  • TABLE 241. GLOBAL SURGICAL DEVICES MARKET SIZE, BY PORTABLE, BY REGION, 2018-2024 (USD MILLION)
  • TABLE 242. GLOBAL SURGICAL DEVICES MARKET SIZE, BY PORTABLE, BY REGION, 2025-2032 (USD MILLION)
  • TABLE 243. GLOBAL SURGICAL DEVICES MARKET SIZE, BY PORTABLE, BY GROUP, 2018-2024 (USD MILLION)
  • TABLE 244. GLOBAL SURGICAL DEVICES MARKET SIZE, BY PORTABLE, BY GROUP, 2025-2032 (USD MILLION)
  • TABLE 245. GLOBAL SURGICAL DEVICES MARKET SIZE, BY PORTABLE, BY COUNTRY, 2018-2024 (USD MILLION)
  • TABLE 246. GLOBAL SURGICAL DEVICES MARKET SIZE, BY PORTABLE, BY COUNTRY, 2025-2032 (USD MILLION)
  • TABLE 247. GLOBAL SURGICAL DEVICES MARKET SIZE, BY STATIONARY, BY REGION, 2018-2024 (USD MILLION)
  • TABLE 248. GLOBAL SURGICAL DEVICES MARKET SIZE, BY STATIONARY, BY REGION, 2025-2032 (USD MILLION)
  • TABLE 249. GLOBAL SURGICAL DEVICES MARKET SIZE, BY STATIONARY, BY GROUP, 2018-2024 (USD MILLION)
  • TABLE 250. GLOBAL SURGICAL DEVICES MARKET SIZE, BY STATIONARY, BY GROUP, 2025-2032 (USD MILLION)
  • TABLE 251. GLOBAL SURGICAL DEVICES MARKET SIZE, BY STATIONARY, BY COUNTRY, 2018-2024 (USD MILLION)
  • TABLE 252. GLOBAL SURGICAL DEVICES MARKET SIZE, BY STATIONARY, BY COUNTRY, 2025-2032 (USD MILLION)
  • TABLE 253. GLOBAL SURGICAL DEVICES MARKET SIZE, BY DISTRIBUTION, 2018-2024 (USD MILLION)
  • TABLE 254. GLOBAL SURGICAL DEVICES MARKET SIZE, BY DISTRIBUTION, 2025-2032 (USD MILLION)
  • TABLE 255. GLOBAL SURGICAL DEVICES MARKET SIZE, BY DIRECT SALES, BY REGION, 2018-2024 (USD MILLION)
  • TABLE 256. GLOBAL SURGICAL DEVICES MARKET SIZE, BY DIRECT SALES, BY REGION, 2025-2032 (USD MILLION)
  • TABLE 257. GLOBAL SURGICAL DEVICES MARKET SIZE, BY DIRECT SALES, BY GROUP, 2018-2024 (USD MILLION)
  • TABLE 258. GLOBAL SURGICAL DEVICES MARKET SIZE, BY DIRECT SALES, BY GROUP, 2025-2032 (USD MILLION)
  • TABLE 259. GLOBAL SURGICAL DEVICES MARKET SIZE, BY DIRECT SALES, BY COUNTRY, 2018-2024 (USD MILLION)
  • TABLE 260. GLOBAL SURGICAL DEVICES MARKET SIZE, BY DIRECT SALES, BY COUNTRY, 2025-2032 (USD MILLION)
  • TABLE 261. GLOBAL SURGICAL DEVICES MARKET SIZE, BY DISTRIBUTORS, BY REGION, 2018-2024 (USD MILLION)
  • TABLE 262. GLOBAL SURGICAL DEVICES MARKET SIZE, BY DISTRIBUTORS, BY REGION, 2025-2032 (USD MILLION)
  • TABLE 263. GLOBAL SURGICAL DEVICES MARKET SIZE, BY DISTRIBUTORS, BY GROUP, 2018-2024 (USD MILLION)
  • TABLE 264. GLOBAL SURGICAL DEVICES MARKET SIZE, BY DISTRIBUTORS, BY GROUP, 2025-2032 (USD MILLION)
  • TABLE 265. GLOBAL SURGICAL DEVICES MARKET SIZE, BY DISTRIBUTORS, BY COUNTRY, 2018-2024 (USD MILLION)
  • TABLE 266. GLOBAL SURGICAL DEVICES MARKET SIZE, BY DISTRIBUTORS, BY COUNTRY, 2025-2032 (USD MILLION)
  • TABLE 267. GLOBAL SURGICAL DEVICES MARKET SIZE, BY ONLINE SALES, BY REGION, 2018-2024 (USD MILLION)
  • TABLE 268. GLOBAL SURGICAL DEVICES MARKET SIZE, BY ONLINE SALES, BY REGION, 2025-2032 (USD MILLION)
  • TABLE 269. GLOBAL SURGICAL DEVICES MARKET SIZE, BY ONLINE SALES, BY GROUP, 2018-2024 (USD MILLION)
  • TABLE 270. GLOBAL SURGICAL DEVICES MARKET SIZE, BY ONLINE SALES, BY GROUP, 2025-2032 (USD MILLION)
  • TABLE 271. GLOBAL SURGICAL DEVICES MARKET SIZE, BY ONLINE SALES, BY COUNTRY, 2018-2024 (USD MILLION)
  • TABLE 272. GLOBAL SURGICAL DEVICES MARKET SIZE, BY ONLINE SALES, BY COUNTRY, 2025-2032 (USD MILLION)
  • TABLE 273. GLOBAL SURGICAL DEVICES MARKET SIZE, BY REGION, 2018-2024 (USD MILLION)
  • TABLE 274. GLOBAL SURGICAL DEVICES MARKET SIZE, BY REGION, 2025-2032 (USD MILLION)
  • TABLE 275. AMERICAS SURGICAL DEVICES MARKET SIZE, BY SUBREGION, 2018-2024 (USD MILLION)
  • TABLE 276. AMERICAS SURGICAL DEVICES MARKET SIZE, BY SUBREGION, 2025-2032 (USD MILLION)
  • TABLE 277. AMERICAS SURGICAL DEVICES MARKET SIZE, BY PRODUCT, 2018-2024 (USD MILLION)
  • TABLE 278. AMERICAS SURGICAL DEVICES MARKET SIZE, BY PRODUCT, 2025-2032 (USD MILLION)
  • TABLE 279. AMERICAS SURGICAL DEVICES MARKET SIZE, BY ENERGY-BASED DEVICES, 2018-2024 (USD MILLION)
  • TABLE 280. AMERICAS SURGICAL DEVICES MARKET SIZE, BY ENERGY-BASED DEVICES, 2025-2032 (USD MILLION)
  • TABLE 281. AMERICAS SURGICAL DEVICES MARKET SIZE, BY SURGICAL IMPLANTS, 2018-2024 (USD MILLION)
  • TABLE 282. AMERICAS SURGICAL DEVICES MARKET SIZE, BY SURGICAL IMPLANTS, 2025-2032 (USD MILLION)
  • TABLE 283. AMERICAS SURGICAL DEVICES MARKET SIZE, BY SURGICAL INSTRUMENTS, 2018-2024 (USD MILLION)
  • TABLE 284. AMERICAS SURGICAL DEVICES MARKET SIZE, BY SURGICAL INSTRUMENTS, 2025-2032 (USD MILLION)
  • TABLE 285. AMERICAS SURGICAL DEVICES MARKET SIZE, BY APPLICATION, 2018-2024 (USD MILLION)
  • TABLE 286. AMERICAS SURGICAL DEVICES MARKET SIZE, BY APPLICATION, 2025-2032 (USD MILLION)
  • TABLE 287. AMERICAS SURGICAL DEVICES MARKET SIZE, BY TECHNOLOGY, 2018-2024 (USD MILLION)
  • TABLE 288. AMERICAS SURGICAL DEVICES MARKET SIZE, BY TECHNOLOGY, 2025-2032 (USD MILLION)
  • TABLE 289. AMERICAS SURGICAL DEVICES MARKET SIZE, BY MINIMALLY INVASIVE, 2018-2024 (USD MILLION)
  • TABLE 290. AMERICAS SURGICAL DEVICES MARKET SIZE, BY MINIMALLY INVASIVE, 2025-2032 (USD MILLION)
  • TABLE 291. AMERICAS SURGICAL DEVICES MARKET SIZE, BY END USER, 2018-2024 (USD MILLION)
  • TABLE 292. AMERICAS SURGICAL DEVICES MARKET SIZE, BY END USER, 2025-2032 (USD MILLION)
  • TABLE 293. AMERICAS SURGICAL DEVICES MARKET SIZE, BY MATERIAL, 2018-2024 (USD MILLION)
  • TABLE 294. AMERICAS SURGICAL DEVICES MARKET SIZE, BY MATERIAL, 2025-2032 (USD MILLION)
  • TABLE 295. AMERICAS SURGICAL DEVICES MARKET SIZE, BY PORTABILITY, 2018-2024 (USD MILLION)
  • TABLE 296. AMERICAS SURGICAL DEVICES MARKET SIZE, BY PORTABILITY, 2025-2032 (USD MILLION)
  • TABLE 297. AMERICAS SURGICAL DEVICES MARKET SIZE, BY DISTRIBUTION, 2018-2024 (USD MILLION)
  • TABLE 298. AMERICAS SURGICAL DEVICES MARKET SIZE, BY DISTRIBUTION, 2025-2032 (USD MILLION)
  • TABLE 299. NORTH AMERICA SURGICAL DEVICES MARKET SIZE, BY COUNTRY, 2018-2024 (USD MILLION)
  • TABLE 300. NORTH AMERICA SURGICAL DEVICES MARKET SIZE, BY COUNTRY, 2025-2032 (USD MILLION)
  • TABLE 301. NORTH AMERICA SURGICAL DEVICES MARKET SIZE, BY PRODUCT, 2018-2024 (USD MILLION)
  • TABLE 302. NORTH AMERICA SURGICAL DEVICES MARKET SIZE, BY PRODUCT, 2025-2032 (USD MILLION)
  • TABLE 303. NORTH AMERICA SURGICAL DEVICES MARKET SIZE, BY ENERGY-BASED DEVICES, 2018-2024 (USD MILLION)
  • TABLE 304. NORTH AMERICA SURGICAL DEVICES MARKET SIZE, BY ENERGY-BASED DEVICES, 2025-2032 (USD MILLION)
  • TABLE 305. NORTH AMERICA SURGICAL DEVICES MARKET SIZE, BY SURGICAL IMPLANTS, 2018-2024 (USD MILLION)
  • TABLE 306. NORTH AMERICA SURGICAL DEVICES MARKET SIZE, BY SURGICAL IMPLANTS, 2025-2032 (USD MILLION)
  • TABLE 307. NORTH AMERICA SURGICAL DEVICES MARKET SIZE, BY SURGICAL INSTRUMENTS, 2018-2024 (USD MILLION)
  • TABLE 308. NORTH AMERICA SURGICAL DEVICES MARKET SIZE, BY SURGICAL INSTRUMENTS, 2025-2032 (USD MILLION)
  • TABLE 309. NORTH AMERICA SURGICAL DEVICES MARKET SIZE, BY APPLICATION, 2018-2024 (USD MILLION)
  • TABLE 310. NORTH AMERICA SURGICAL DEVICES MARKET SIZE, BY APPLICATION, 2025-2032 (USD MILLION)
  • TABLE 311. NORTH AMERICA SURGICAL DEVICES MARKET SIZE, BY TECHNOLOGY, 2018-2024 (USD MILLION)
  • TABLE 312. NORTH AMERICA SURGICAL DEVICES MARKET SIZE, BY TECHNOLOGY, 2025-2032 (USD MILLION)
  • TABLE 313. NORTH AMERICA SURGICAL DEVICES MARKET SIZE, BY MINIMALLY INVASIVE, 2018-2024 (USD MILLION)
  • TABLE 314. NORTH AMERICA SURGICAL DEVICES MARKET SIZE, BY MINIMALLY INVASIVE, 2025-2032 (USD MILLION)
  • TABLE 315. NORTH AMERICA SURGICAL DEVICES MARKET SIZE, BY END USER, 2018-2024 (USD MILLION)
  • TABLE 316. NORTH AMERICA SURGICAL DEVICES MARKET SIZE, BY END USER, 2025-2032 (USD MILLION)
  • TABLE 317. NORTH AMERICA SURGICAL DEVICES MARKET SIZE, BY MATERIAL, 2018-2024 (USD MILLION)
  • TABLE 318. NORTH AMERICA SURGICAL DEVICES MARKET SIZE, BY MATERIAL, 2025-2032 (USD MILLION)
  • TABLE 319. NORTH AMERICA SURGICAL DEVICES MARKET SIZE, BY PORTABILITY, 2018-2024 (USD MILLION)
  • TABLE 320. NORTH AMERICA SURGICAL DEVICES MARKET SIZE, BY PORTABILITY, 2025-2032 (USD MILLION)
  • TABLE 321. NORTH AMERICA SURGICAL DEVICES MARKET SIZE, BY DISTRIBUTION, 2018-2024 (USD MILLION)
  • TABLE 322. NORTH AMERICA SURGICAL DEVICES MARKET SIZE, BY DISTRIBUTION, 2025-2032 (USD MILLION)
  • TABLE 323. LATIN AMERICA SURGICAL DEVICES MARKET SIZE, BY COUNTRY, 2018-2024 (USD MILLION)
  • TABLE 324. LATIN AMERICA SURGICAL DEVICES MARKET SIZE, BY COUNTRY, 2025-2032 (USD MILLION)
  • TABLE 325. LATIN AMERICA SURGICAL DEVICES MARKET SIZE, BY PRODUCT, 2018-2024 (USD MILLION)
  • TABLE 326. LATIN AMERICA SURGICAL DEVICES MARKET SIZE, BY PRODUCT, 2025-2032 (USD MILLION)
  • TABLE 327. LATIN AMERICA SURGICAL DEVICES MARKET SIZE, BY ENERGY-BASED DEVICES, 2018-2024 (USD MILLION)
  • TABLE 328. LATIN AMERICA SURGICAL DEVICES MARKET SIZE, BY ENERGY-BASED DEVICES, 2025-2032 (USD MILLION)
  • TABLE 329. LATIN AMERICA SURGICAL DEVICES MARKET SIZE, BY SURGICAL IMPLANTS, 2018-2024 (USD MILLION)
  • TABLE 330. LATIN AMERICA SURGICAL DEVICES MARKET SIZE, BY SURGICAL IMPLANTS, 2025-2032 (USD MILLION)
  • TABLE 331. LATIN AMERICA SURGICAL DEVICES MARKET SIZE, BY SURGICAL INSTRUMENTS, 2018-2024 (USD MILLION)
  • TABLE 332. LATIN AMERICA SURGICAL DEVICES MARKET SIZE, BY SURGICAL INSTRUMENTS, 2025-2032 (USD MILLION)
  • TABLE 333. LATIN AMERICA SURGICAL DEVICES MARKET SIZE, BY APPLICATION, 2018-2024 (USD MILLION)
  • TABLE 334. LATIN AMERICA SURGICAL DEVICE